{"transactions":[{"id":2665891,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T18:06:19.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":51724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 51,724 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 51,724 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":51724,"derivative":{"exercise_price":3.17,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":51724},"source":{"system":"sec-edgar","filing":"0000899243-21-024208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000089924321024208/doc4.xml","form_type":"4"}},{"id":2665890,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T18:06:19.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":29183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 29,183 restricted stock units, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":47518,"source":{"system":"sec-edgar","filing":"0000899243-21-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000089924321024208/doc4.xml","form_type":"4"}},{"id":2846327,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T16:16:16.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":30000,"derivative":{"exercise_price":1.78,"expiration_date":"2031-02-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-21-010580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010580/ownership.xml","form_type":"4"}},{"id":2846326,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:16:16.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":20225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 17, 2021, Reporting Person was granted 20,225 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":97689,"source":{"system":"sec-edgar","filing":"0001213900-21-010580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010580/ownership.xml","form_type":"4"}},{"id":2846325,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:16:16.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 17, 2021, Reporting Person was granted 30,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":77464,"source":{"system":"sec-edgar","filing":"0001213900-21-010580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010580/ownership.xml","form_type":"4"}},{"id":2907237,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-01-14T09:04:41.000Z","date":"2021-01-12","kind":"grant","acquired":true,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 12, 2021, Reporting Person was granted 8,334 shares of Common Stock as compensation for Reporting Persons service as a director during the fourth quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":47464,"source":{"system":"sec-edgar","filing":"0001213900-21-002118","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021002118/ownership.xml","form_type":"4"}},{"id":2908067,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T16:26:12.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-000985","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000156761921000985/doc1.xml","form_type":"4"}},{"id":3008322,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-10-13T17:02:24.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":9430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 12, 2020, Reporting Person was granted 9,430 shares of Common Stock as compensation for Reporting Persons service as a director during the third quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":39130,"source":{"system":"sec-edgar","filing":"0001213900-20-031107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020031107/ownership.xml","form_type":"4"}},{"id":3084386,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-07-13T16:15:07.000Z","date":"2020-07-10","kind":"grant","acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 10, 2020, Reporting Person was granted 7,200 shares of Common Stock as compensation for Reporting Persons service as a director during the second quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":29700,"source":{"system":"sec-edgar","filing":"0001213900-20-017336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020017336/ownership.xml","form_type":"4"}},{"id":3284637,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T16:36:49.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 50% of the shares on February 6, 2021, and the remaining shares will become exercisable on February 6, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":12500,"derivative":{"exercise_price":2.16,"expiration_date":"2030-02-06","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-20-002931","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002931/ownership.xml","form_type":"4"}},{"id":3284636,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-02-07T16:36:49.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2020, Reporting Person was granted 12,500 Common Stock restricted stock units. The restricted stock units vest as to 50% of the shares on February 6, 2021, and the remaining restricted stock unit shares vest on February 6, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":22500,"source":{"system":"sec-edgar","filing":"0001213900-20-002931","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002931/ownership.xml","form_type":"4"}},{"id":3311449,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T17:51:15.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-001042","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000156761920001042/doc1.xml","form_type":"4"}},{"id":3653858,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T17:01:26.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\"). The option becomes exercisable as to 50% of the shares on February 13, 2020, and the remaining shares will become exercisable on February 13, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":25000,"derivative":{"exercise_price":4.3,"expiration_date":"2029-02-13","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001615774-19-002641","document":"s116119_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577419002641/s116119_form4.xml","form_type":"4"}},{"id":3682467,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T16:07:33.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-002191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000089924319002191/doc4.xml","form_type":"4"}},{"id":3936760,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-11T16:07:00.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 9, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":15.6,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-012528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199310/000089924318012528/doc4.xml","form_type":"4"}},{"id":4044451,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":138169,"kind":"person","name":"NUSSBAUM SAMUEL R MD","position":1,"cik":"0001199310","reported_name":"NUSSBAUM SAMUEL R MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-02-21T06:05:17.000Z","date":"2018-02-16","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on February 16, 2018."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-18-002418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315218002418/form4.xml","form_type":"4"}}]}